HRTX
Heron TherapeutiNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$148.83M
P/E Ratio
—
EPS
$-0.12
Beta
1.42
52W High
$2.61
52W Low
$0.74
50-Day MA
$1.07
200-Day MA
$1.35
Dividend Yield
—
Profit Margin
-13.00%
Forward P/E
46.95
PEG Ratio
-0.18
About Heron Therapeuti
Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $154.90M |
| Gross Profit (TTM) | $112.52M |
| EBITDA | -224,000 |
| Operating Margin | 0.09% |
| Return on Equity | -2409.00% |
| Return on Assets | -0.65% |
| Revenue/Share (TTM) | $0.93 |
| Book Value | $0.07 |
| Price-to-Book | 11.34 |
| Price-to-Sales (TTM) | 0.96 |
| EV/Revenue | 1.586 |
| EV/EBITDA | 35.04 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -0.50% |
| Shares Outstanding | $188.54M |
| Float | $133.74M |
| % Insiders | 0.82% |
| % Institutions | 83.69% |
Analyst Ratings
Consensus ($4.33 target)
1
Strong Buy2
BuyData last updated: 4/8/2026